S&P 500 7,757.17 +0.58%
Nasdaq 26,702.86 +1.05%
S&P/TSX 36,324.99 +0.60%
Apple 343.99 +0.31%
Nvidia 221.97 +2.25%
Microsoft 532.95 −0.11%
Shopify 244.93 +0.38%
Royal Bank 283.62 +1.23%
CAD/USD 0.7121 +0.17%
CLOSED · 20:20 ET
Market ClerkRecap
Wed Oct 21 · markets closed2 signals today78 insider buys this week · $240.8MCIRO short report next: Oct 31The week ahead
SS
INSIDER · TXG · 10x Genomics, Inc. · DIRECTOR

SULIMAN SHEHNAAZ

Every open-market transaction filed under this name, Aug 24 to Sep 22.

Filings
7
0 buys · 7 sells
Bought
—
open market, at cost
Sold
$605K
includes scheduled sales
Buys since
—
no current price on file

Filings

SEC FORM 4 · OPEN MARKET
TradedTickerCompanyRoleTypeSharesPriceValueSince
Sep 22TXG10x Genomics, Inc.DirectorSell1,222$82.28$101K—
Sep 22TXG10x Genomics, Inc.DirectorSell2,270$81.67$185K—
Sep 22TXG10x Genomics, Inc.DirectorSell1,325$80.82$107K—
Sep 22TXG10x Genomics, Inc.DirectorSell614$79.51$49K—
Sep 22TXG10x Genomics, Inc.DirectorSell292$78.20$23K—
Aug 24TXG10x Genomics, Inc.DirectorSell1,646$63.97$105K—
Aug 24TXG10x Genomics, Inc.DirectorSell561$62.73$35K—

"Since" is the stock's move from the filed price to the latest quote on file, not a scored call. Open-market purchases and sales only; option exercises and grants are excluded.